CONGRESS
20 - 22
JANUARY
2026
WTC São Paulo, Brazil
A historic gathering advancing Epidermolysis Bullosa research and care.
Innovation Arena
23
JANUARY
2026
THE EB 2026
INTERNATIONAL CONGRESS
IS COMING TO BRAZIL!
From January 20 to 22, São Paulo will host the leading global event dedicated to Epidermolysis Bullosa (EB), bringing together experts, patients, researchers, and leaders from over 50 countries for a unique and transformative gathering.
Registration
20 - 22
JANUARY
2026
A NEW ERA FOR EB CARE AND RESEARCH
Organized by DEBRA Brasil, in partnership with DEBRA International and EB Clinet, the EB 2026 Congress marks the first edition to be held in South America.
It will be a unique moment to strengthen global networks, promote decentralized research, and give visibility to emerging regions in the care of Epidermolysis Bullosa.
INNOVATION
ARENA
JOIN THE INNOVATION ARENA
Stay one more day in São Paulo and take part in the Innovation Arena, a high-level side event focused on accelerating medical innovation in EB. Connect with global leaders, biotechs, researchers, and patient organizations in a dynamic session of pitches, discussions, and future-shaping ideas.
Don’t miss this unique opportunity beyond the main program.
23
JANUARY
2026
in colaboration with
The EB 2026 International Congress is the premier global event dedicated to Epidermolysis Bullosa
Expected audience
500+ participants
From over
50 countries
ABSTRACTS
Abstract submission closed
Envios encerrados
Please note: you must be enrolled in EB 2026 to be able to submit your abstract
We invite researchers, clinicians, and members of the EB community to submit their scientific abstracts for presentation at the EB2026 Congress. Selected abstracts will be presented either as oral and poster communications or as poster presentations only, according to the official congress schedule.
Each participant may submit up to two (2) abstracts as first author. Abstract submissions will be accepted only from participants who have completed their registration and payment.
Abstract Format and Submission Details:
-
Abstracts must be submitted in English only.
-
Submissions must be made via the online submission form, which includes a text field and the obligation to upload a file (Word or PDF) containing the same text along with the title, authors, and affiliations.
-
The abstract must not exceed 500 words.
-
You may include one (1) image (optional graphical abstract), which will be counted as 300 words.
-
Keywords are required and must be entered in the designated field.
-
No revisions will be accepted after submission.
-
Submission period: June 30 to September 15, 2025.
-
Notification of results: October 30, 2025.
-
Abstracts will be evaluated as submitted; there will be no revision phase.
We look forward to receiving your contributions and showcasing the latest advances and insights from around the world at EB2026!
For any questions, please contact the Scientific Committee at: eb2026@debrabrasil.com.br
VENUE AND ACCESS
WTC Events Center – São Paulo, Brazil
A modern facility in a strategic location, offering easy access for participants from both Brazil and abroad. Accommodation suggestions and transportation routes will be provided soon.
OFFICIAL AGENCY
We are pleased to announce that Cisalpina Tours is the official travel agency of EB2026. We encourage all participants to contact them for assistance with their trip to Brazil, including access to special hotel rates and trusted services arranged in partnership with the Congress.
Hotel Reservations
Transfers
Flight Bookings
Tourist Services
SPEAKERS & GUESTS
GLOBAL LEADERS GATHERED IN ONE PLACE
EB 2026 will feature internationally recognized experts in genetics, dermatology, clinical care, and scientific innovation. Meet the leading voices driving progress in EB treatment, along with special guests who will bring inspiration and fresh perspectives to the event.
SCIENTIFIC COMMITTEE
TARGET
AUDIENCE
& IMPACT
CONGRESS — A COMMUNITY UNITED FOR TRANSFORMATION
Aimed at researchers, physicians, healthcare professionals, patients, families, NGO representatives, and industry leaders, EB 2026 is a gathering for those who want to make a difference.
WHY THIS CONGRESS MATTERS
For researchers
Brazil represents a frontier for genetic and clinical studies.
For clinicians
A unique opportunity to engage with global leaders in EB care.
For patients and families
A source of hope through access to new treatments and expanded trials.
For DEBRA/EB Advocacy Groups
A chance to strengthen the global network of DEBRA organizations ensure impactul adovcacy for the EB community.
TESTIMONIALS
Brazil’s genetic sequencing efforts offer hope for EB patients worldwide.
Dr. Peter Marinkovich
This Congress reflects our commitment to decentralizing research and expanding transformative care.
Ritu Jain
President of DEBRA International
SPONSORS
DIAMOND
PLATINUM
GOLD
FRIENDS
.jpg){kind=small}
CONTACT
EXHIBITORS
& SPONSORS
Leandro L. Rossi President of DEBRA BRASIL
ACCOMMODATION
& AIR TRAVEL
